◆英語タイトル：DAE HWA Pharmaceutical Co., Ltd. (067080) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
DAE HWA Pharmaceutical Co., Ltd. (DAE HWA) is a specialized pharmaceutical company. It conducts the research and manufacture of prescription and over-the-counter (OTC) finished pharmaceutical products. The company also manufactures APIs.These drugs are aimed at the prevention and treatment of various diseases and disorders including menopausal disorders, peptic ulcer and cancer, among others. The company manufactures about 130 pharmaceutical products and has 267 products approved by the Ministry of Food and Drug Safety in Korea. Its product portfolio consists of analgesics and anti-inflammatory drugs and antipyretics, antihistamines, central nervous system, skeletal muscle relaxants, corticosteroids, cardiovascular drugs, cough suppressants, expectorants and mucolytics among others. In some of its products, the company incorporated the Transdermal Drug Delivery System (TDDS), which facilitates the non-invasive delivery of medication from the surface of the skin. The company has a cGMP manufacturing facility in Gangwon-Do, which is in compliance with the FDA and the EMA. The company exports its products to 22 countries in Asia, South America, Africa and the Middle East. DAE HWA is headquartered in Gangwon-Do, South Korea.
DAE HWA Pharmaceutical Co., Ltd. Key Recent Developments
Aug 14, 2013: Dae Hwa Pharm’s Co-CEO Noh Byeong Tae Resigns
This comprehensive SWOT profile of DAE HWA Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of DAE HWA Pharmaceutical Co., Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
DAE HWA Pharmaceutical Co., Ltd. – Key Information
DAE HWA Pharmaceutical Co., Ltd. – Overview
DAE HWA Pharmaceutical Co., Ltd. – Key Employees
DAE HWA Pharmaceutical Co., Ltd. – Key Employee Biographies
DAE HWA Pharmaceutical Co., Ltd. – Key Operational Heads
DAE HWA Pharmaceutical Co., Ltd. – Major Products and Services
DAE HWA Pharmaceutical Co., Ltd. – History
DAE HWA Pharmaceutical Co., Ltd. – Company Statement
DAE HWA Pharmaceutical Co., Ltd. – Locations And Subsidiaries
DAE HWA Pharmaceutical Co., Ltd. – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
DAE HWA Pharmaceutical Co., Ltd. – Business Description
DAE HWA Pharmaceutical Co., Ltd. – Corporate Strategy
DAE HWA Pharmaceutical Co., Ltd. – SWOT Analysis
SWOT Analysis – Overview
DAE HWA Pharmaceutical Co., Ltd. – Strengths
DAE HWA Pharmaceutical Co., Ltd. – Weaknesses
DAE HWA Pharmaceutical Co., Ltd. – Opportunities
DAE HWA Pharmaceutical Co., Ltd. – Threats
DAE HWA Pharmaceutical Co., Ltd. – Key Competitors
Section 3 – Company Financial Performance Charts
DAE HWA Pharmaceutical Co., Ltd. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company